Is Ellume listed on the ASX?

Why is it so hard to find the healthcare company Ellume on the ASX? That's because it's a private company. Here's what we know.

A sign saying private on a glass window

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Ellume has been a company on every investors' lips over the past couple of months. The Brisbane-based medical company has been at the vanguard of Australia's contribution to fighting the coronavirus pandemic.

The company has pioneered an 'at-home' test for COVID-19. Patients can use this test to get an accurate result within 15 minutes without seeing a doctor or getting the test analysed at a lab.

You can look, but you can't own…

So, very understandably, many ASX investors have been looking for ways to invest in Ellume on the ASX. Some are even going as far as searching for an Ellume ticker code. Unfortunately, those efforts have been and will continue to be, fruitless. See, Ellume is a private company, with its shares unavailable for public investors to trade and invest in.

According to a report in the Australian Financial Review (AFR) this week, Ellume actually was considering an ASX-listing through an initial public offering (IPO) around 2½ years ago. The company reportedly even went as far as hiring PAC Partners to assist it with a pre-IPO capital raise and a subsequent listing on the ASX. But alas for its would-be shareholders, this process didn't end up eventuating.

As a private company, Ellume does have shares (84 million according to the AFR report). They are held by a small group of founders, employees and investors at Ellume though. The AFR tells us that Ellume chair and investor Paul Darrouzet holds a quarter of Ellume's shares. Dr Sean Parsons, Ellume's founder and managing director, owns another 14 million.

The rest of Ellume's board also reportedly has ownership stakes. Options and performance shares are often part of board members' salaries as well.

How much are Ellume's shares worth?

It's hard to say exactly how much Ellume and its shares are worth, seeing as the data is not in the public arena. But guesses in the billions are probably not wild. That's because (as we reported at the time) Ellume has recently signed a massive US$250 million contract with the US government to supply 8.5 million testing kits. The deal also involves Ellume building a factory on US soil to meet demand.

Can you invest in Ellume on the ASX?

As we've discussed, you can't directly invest in Ellume on the ASX. However, there are a few other ASX-listed companies that operate in the same space as Ellume. These include Atomo Diagnostics Ltd (ASX: AT1) and Anteotech Ltd (ASX: ADO).

Indeed, Anteotech shares spiked 95% last week on news that it was continuing to work with Ellume in providing some of the technology that goes into the testing.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Broker Notes

3 of the best ASX stocks to buy now with $2,500

These shares are highly rated by the team at Bell Potter.

Read more »

Man smiling on top of rocks with mountains in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were in a nervous mood today.

Read more »

A man in suit and tie is smug about his suitcase bursting with cash.
Broker Notes

2 big-name ASX 200 shares brokers rate as top buys

Let's see which shares could be in the buy zone right now.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Block, Catalyst Metals, Coronado Global, and Pilbara Minerals shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why Beach Energy, Boss Energy, Cochlear, and Light & Wonder shares are pushing higher

These shares are having a good time on hump day. But why?

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Mergers & Acquisitions

Guess which ASX 300 stock is jumping 7% on merger news

This struggling company could be close to merging with a rival.

Read more »

a man in hard hat and high visibility vest talks into a walky-talky device in the foreground of a freight train at a railway yard.
Share Market News

What does the new BHP contract means for Aurizon shares?

This broker sees upside based on a new deal between Aurizon Holdings and BHP. 

Read more »